GlobeNewswire Inc.··DelveinsightPharma Giants Race to Dominate Severe Asthma Market With 35+ Pipeline Drugs
Over 30 pharma companies develop 35+ severe asthma drugs with recent approvals validating new mechanisms, signaling major market opportunity and competitive intensity ahead.
AZNUPBGSKGENBFDA approvalclinical trials